Losing weight while on hormone therapy

What changes in your body around menopause

The Study of Women's Health Across the Nation (SWAN) tracked more than 1,200 women through the menopause transition. Fat mass began rising faster, and lean mass began falling, about two years before the final period, with changes continuing until about two years afterward. Total weight rose steadily through midlife without a sudden jump at menopause.

Importantly for this question, the SWAN analysis found that hormone therapy use did not independently affect these changes. The shift in body composition is part of the transition itself, alongside aging, rather than a side effect of treatment.

Why it feels harder now

• Loss of muscle, which lowers the energy your body uses at rest and makes activity feel harder
• Fat moving toward the abdomen, even when the scale barely changes
• Night sweats and broken sleep, which raise appetite and make food choices harder
• Gradual declines in insulin sensitivity
• Less daily movement, often from busy work and caregiving years
• Joint aches, low mood or fatigue that make exercise less appealing
• Alcohol, which adds calories and disrupts sleep

Why a plateau can coincide with starting treatment

Many women begin hormone therapy in their late 40s or 50s, exactly when these changes are peaking. It is natural to blame the new medicine for a stall that was already underway. In the first weeks, some women also notice bloating or breast fullness, which is usually fluid rather than fat and often settles as the body adjusts.

If the early bloating has not settled after a couple of months, mention it. Your clinician may adjust the dose, route or type of progestogen.

How hormone therapy can help indirectly

The Menopause Society describes hormone therapy as the most effective treatment for hot flashes and night sweats. When night sweats calm down, sleep usually improves, and better sleep makes it easier to manage hunger, energy and motivation to move. The NIDDK notes that not getting enough sleep is linked to weight gain.

Some research suggests women on hormone therapy accumulate less abdominal fat for a given weight, but this effect is modest and hormone therapy is not prescribed as a weight treatment.

What to measure instead of the scale

Because muscle is being lost while fat is gained, the scale can hide real progress. Waist circumference is a simple, useful marker of abdominal fat. Strength, measured by the weights you can lift or the stairs you can climb, reflects muscle. How your clothes fit, your energy and your blood pressure, glucose and lipid results tell you more than a single body weight number.

A simple weekly structure

None of these needs to be perfect. Consistency over months matters far more than intensity in any single week.

• Two or three short strength sessions covering legs, back, chest and core
• Brisk walking or cycling on most days, adding up to at least 150 minutes
• A protein source at every meal, such as eggs, fish, poultry, dairy, tofu or legumes
• Alcohol-free evenings on most nights of the week
• A consistent bedtime and wake time, even on weekends

What tends to help most in this window

Strength training two or more days a week is the single most valuable step, because it directly counters muscle loss. The CDC recommends muscle-strengthening activity on at least two days plus 150 minutes of moderate aerobic activity each week. Even small amounts help.

Prioritize protein at each meal to support muscle, keep alcohol low, aim for seven to nine hours of sleep and build more walking into your day. The Menopause Society notes that losing as little as 3% of body weight can benefit women with overweight, with larger losses bringing further benefits.

When medical weight management makes sense

If habits alone are not enough and you meet medical criteria, weight-loss medicines can be used alongside hormone therapy. GLP-1 medicines such as semaglutide and tirzepatide can produce substantial weight loss, and they can be combined with hormone therapy under a clinician's care. Rapid weight loss can bring temporary hair shedding and muscle loss, which is another reason to keep up strength training and protein.

GLP-1 medicines commonly cause nausea, constipation or diarrhea, carry a boxed warning about thyroid C-cell tumors (they are not used with a personal or family history of medullary thyroid cancer or MEN2), can cause pancreatitis and gallbladder problems, and are not used in pregnancy. Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as Wegovy or Zepbound.

At HealifyMD, compounded semaglutide injection starts from $299/month and compounded tirzepatide injection from $399/month. HealifyMD's hormone therapy plan for women is $349 for the first month (including the evaluation and baseline labs), then $99/month, with estradiol, estriol vaginal cream and progesterone included in the hormone therapy program. Compounded hormones are not FDA-approved and are not equivalent to branded products. Other labs are priced separately, and your price is confirmed at the eligibility review.